Early research (Phase 1)Study completedNCT02955251What this trial is testingABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 61
Early research (Phase 1)Ended earlyNCT04099277What this trial is testingLY3435151 in Participants With Solid TumorsWho this might be right forSolid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more Eli Lilly and Company 2
Early research (Phase 1)Active Not RecruitingNCT05239143What this trial is testingP-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsWho this might be right forBreast CancerOvarian CancerNon Small Cell Lung Cancer+6 more Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 1,109
Not applicableLooking for participantsNCT04981119What this trial is testingSolid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingWho this might be right forSolid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more A2 Biotherapeutics Inc. 200
Early research (Phase 1)UnknownNCT04660929What this trial is testingCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsWho this might be right forHER2-positiveAdenocarcinomaBile Duct Cancer+28 more Carisma Therapeutics Inc 48
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Early research (Phase 1)Ended earlyNCT04628780What this trial is testingStudy to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid TumorsWho this might be right forNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and NeckRenal Cell Carcinoma+3 more Pfizer 37
Early research (Phase 1)Ended earlyNCT03957096What this trial is testingA Safety Study of SGN-CD47M in Patients With Solid TumorsWho this might be right forSoft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more Seagen Inc. 16
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05941507What this trial is testingEvaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors LigaChem Biosciences, Inc. 300
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Ended earlyNCT04442126What this trial is testingNM21-1480 in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorNon-small Cell Lung CancerColorectal Cancer+6 more Numab Therapeutics AG 52
Not applicableEnrolling By InvitationNCT06885424What this trial is testingA Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsWho this might be right forSolid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more A2 Biotherapeutics Inc. 400
Early research (Phase 1)Study completedNCT06549816What this trial is testingSGN-B6A in Chinese Participants With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma+3 more Seagen, a wholly owned subsidiary of Pfizer 6
Early research (Phase 1)Active Not RecruitingNCT03983954What this trial is testingNaptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Who this might be right forER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more NeoTX Therapeutics Ltd. 120
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15